Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genetic Screens02:46

Genetic Screens

5.9K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.9K
Pedigree Analysis01:35

Pedigree Analysis

90.6K
Overview
90.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Minimal Residual Disease by High-Throughput Sequencing in Standard Risk-Favorable Pediatric B-Lymphoblastic Leukemia.

Blood advances·2026
Same author

Trametinib Therapy for Hypertrophic Cardiomyopathy and Pulmonary Hypertension in a Child With RAF1-Related Noonan Syndrome (p.Ser257Leu): A Case Report.

Clinical case reports·2026
Same author

Therapeutic Targeting of IL-17A-Driven PTGS2/NLRP3 Inflammasome Activation in Juvenile Myelomonocytic Leukemia.

Blood·2026
Same author

Dynamic genetic and nongenetic RAS pathway activation drives resistance to FLT3 and BCL2 inhibitor therapy.

Blood·2026
Same author

Toxicity from asparaginase during acute lymphoblastic leukemia induction: A report from the Children's Oncology Group.

Blood advances·2026
Same author

Reduced-intensity reinduction for children and young persons with relapsed acute lymphoblastic leukemia.

Leukemia·2026

Related Experiment Video

Updated: Mar 24, 2026

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.6K

Pediatric MDS: GATA screen the germline.

Elliot Stieglitz1, Mignon L Loh1

  • 1UNIVERSITY OF CALIFORNIA, SAN FRANCISCO.

Blood
|March 19, 2016
PubMed
Summary
This summary is machine-generated.

Germline mutations in GATA2 are common in children with myelodysplastic syndrome (MDS), particularly those with monosomy 7. This finding is crucial for understanding the genetic basis of pediatric MDS.

More Related Videos

FISH for Pre-implantation Genetic Diagnosis
07:34

FISH for Pre-implantation Genetic Diagnosis

Published on: February 23, 2011

38.0K
Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
09:37

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

10.6K

Related Experiment Videos

Last Updated: Mar 24, 2026

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.6K
FISH for Pre-implantation Genetic Diagnosis
07:34

FISH for Pre-implantation Genetic Diagnosis

Published on: February 23, 2011

38.0K
Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
09:37

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

10.6K

Area of Science:

  • Hematology
  • Genetics
  • Pediatric Oncology

Background:

  • Myelodysplastic syndromes (MDS) are rare in children, affecting 0.8 to 4 cases per million.
  • Germline mutations are increasingly recognized as a cause of pediatric MDS.
  • GATA2 mutations are associated with various hematologic disorders.

Purpose of the Study:

  • To investigate the frequency of germline GATA2 mutations in pediatric patients with myelodysplastic syndrome (MDS).
  • To determine if GATA2 mutations are associated with specific MDS subtypes, such as monosomy 7.
  • To assess the prevalence of GATA2 mutations in different categories of pediatric MDS.

Main Methods:

  • Screening of over 600 pediatric and adolescent patients with primary or secondary MDS.
  • Enrollment in the European Working Group on MDS (EWGs MDS) consortium over 15 years.
  • Genetic analysis to detect germline mutations in the GATA2 gene.

Main Results:

  • Germline GATA2 mutations were identified in 7% of children with primary MDS.
  • In adolescents with MDS and monosomy 7, GATA2 mutations were found in up to 72%.
  • The frequency of GATA2 mutations was higher (15%) in children with advanced MDS.
  • No GATA2 mutations were found in therapy-related MDS or acquired aplastic anemia.

Conclusions:

  • Germline GATA2 mutations are a significant genetic factor in a substantial proportion of pediatric MDS cases.
  • GATA2 mutations are particularly prevalent in pediatric MDS with monosomy 7.
  • These findings highlight the importance of genetic screening for GATA2 in diagnosing and managing pediatric MDS.